Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

The formulated gel is a promising treatment for alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Topical tacrolimus effectively treated scalp lesions, reversed skin atrophy, and promoted hair growth.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.